Single dose of HPV vaccine shows durable protection 15 years after vaccination-Follow up data from IARC cohort study in India

被引：0
|
作者：
Basu, P. [1 ]
机构：
[1] Int Agcy Res Canc, Lyon, France
来源：
INTERNATIONAL JOURNAL OF CANCER | 2024年 / 155卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
000461
引用
收藏
页码：18 / 19
页数：2
相关论文
共 13 条
  • [1] A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: an retrospective cohort study in Fiji
    Reyburn, Rita
    Tuivaga, Evelyn
    Ratu, Tupou
    Young, Seruwaia
    Garland, Suzanne M.
    Murray, Gerald
    Cornall, Alyssa
    Tabrizi, Sepehr
    Nguyen, Cattram D.
    Jenkins, Kylie
    Tikoduadua, Lisi
    Kado, Joseph
    Kama, Mike
    Rafai, Eric
    Devi, Rachel
    Mulholland, Kim
    Fong, James
    Russell, Fiona M.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 37
  • [2] Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination Results from a randomized study
    Romanowski, Barbara
    Schwarz, Tino F.
    Ferguson, Linda M.
    Ferguson, Murdo
    Peters, Klaus
    Dionne, Marc
    Schulze, Karin
    Ramjattan, Brian
    Hillemanns, Peter
    Behre, Ulrich
    Suryakiran, Pemmaraju
    Thomas, Florence
    Struyf, Frank
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1155 - 1165
  • [3] Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study
    Basu, Partha
    Muwonge, Richard
    Bhatla, Neerja
    Nene, Bhagwan M.
    Joshi, Smita
    Esmy, Pulikottil O.
    Poli, Usha Rani Reddy
    Joshi, Geeta
    Verma, Yogesh
    Zomawia, Eric
    Shastri, Surendra S.
    Pimple, Sharmila
    Anantharaman, Devasena
    Prabhu, Priya R.
    Hingmire, Sanjay
    Sauvaget, Catherine
    Lucas, Eric
    Pawlita, Michael
    Gheit, Tarik
    Jayant, Kasturi
    Malvi, Sylla G.
    Siddiqi, Maqsood
    Michel, Angelika
    Butt, Julia
    Sankaran, Subha
    Kannan, Thiraviam Pillai Rameshwari Ammal
    Varghese, Rintu
    Divate, Uma
    Willhauck-Fleckenstein, Martina
    Waterboer, Tim
    Mueller, Martin
    Sehr, Peter
    Vashist, Shachi
    Mishra, Gauravi
    Jadhav, Radhika
    Thorat, Ranjit
    Tommasino, Massimo
    Pillai, M. Radhakrishna
    Sankaranarayanan, Rengaswamy
    PAPILLOMAVIRUS RESEARCH, 2019, 7 : 75 - 81
  • [4] The effects of booster vaccination of hepatitis B vaccine on children 5-15years after primary immunization: A 5-year follow-up study
    Wu, Zikang
    Yao, Jun
    Bao, Hongdan
    Chen, Yongdi
    Lu, Shunshun
    Li, Jing
    Yang, Linna
    Jiang, Zhenggang
    Ren, Jingjing
    Xu, Kai-jin
    Ruan, Bing
    Yang, Shi-gui
    Xie, Tian-sheng
    Li, Qian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1251 - 1256
  • [5] Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India
    Alvarez-Uria, Gerardo
    Naik, Praveen K.
    Pakam, Raghavakalyan
    Midde, Manoranjan
    GLOBAL HEALTH ACTION, 2013, 6 : 1 - 8
  • [6] Precancerous cervical lesions caused by non-vaccine- preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
    Shing, Jaimie Z.
    Hu, Shangying
    Herrero, Rolando
    Hildesheim, Allan
    Porras, Carolina
    Sampson, Joshua N.
    Schussler, John
    Schiller, John T.
    Lowy, Douglas R.
    Sierra, Monica S.
    Carvajal, Loretto
    Kreimer, Aimee R.
    LANCET ONCOLOGY, 2022, 23 (07): : 940 - 949
  • [7] LONG TERM FOLLOW UP OF AN EARLY OLIGOARTHRITIS COHORT SHOWS THAT EARLY AGGRESSIVE INTERVENTION LEADS TO DRUG FREE REMISSION AFTER 10 YEARS: RESULTS FROM THE LOTO STUDY
    Castillo-Gallego, C.
    Green, M. J.
    Aydin, S.
    Nizam, S.
    Emery, P.
    Marzo-Ortega, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 407 - 407
  • [8] Factors associated with loss to follow up after entry into care of HIV infected children ineligible for antiretroviral therapy: data from an HIV cohort study in India
    Praveen Kumar Naik
    Manoranjan Midde
    Raghavakalyan Pakam
    Gerardo Alvarez-Uria
    BMC Infectious Diseases, 14 (Suppl 3)
  • [9] Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study
    Doshi, Reena H.
    Mukadi, Patrick K.
    Casey, Rebecca M.
    Kizito, Gabriel M.
    Gao, Hongjiang
    Nguete, U. Beatrice
    Laven, Janeen
    Sabi, Lilliane
    Kaba, Didine K.
    Muyembe-Tamfum, Jean-Jacques
    Hyde, Terri B.
    Ahuka-Mundeke, Steve
    Staples, J. Erin
    LANCET INFECTIOUS DISEASES, 2024, 24 (06): : 611 - 618
  • [10] Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15-55 years and first-time modelling of antibody responses in mature women: results from an open-label 6-year follow-up study
    Schwarz, T.
    Spaczynski, M.
    Kaufmann, A.
    Wysocki, J.
    Galaj, A.
    Schulze, K.
    Suryakiran, P.
    Thomas, F.
    Descamps, D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (01) : 107 - 118
12